Towa Pharmaceutical , Ltd. Accounts Payable

Towa Pharmaceutical , Ltd. (TWAPF) currently reports a accounts payable of $35B as of June 2026. That compares with $18B in the prior-year period — up 92.3% year over year. Use the charts on this page to explore Towa Pharmaceutical , Ltd.'s accounts payable history and peer comparisons.

Towa Pharmaceutical , Ltd.'s accounts payable increased from $18B to $35B — a 92.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Towa Pharmaceutical , Ltd. reported $35B in accounts payable as of June 2026. That compares with $18B in the prior-year period — up 92.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $35B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Towa Pharmaceutical , Ltd., and consider following TWAPF for alerts when major investors trade the stock.